Drug reshapes tissue architecture to reduce damage in alcohol-related liver disease

Researchers from the Roger Williams Institute of Liver Studies at King’s College London developed two 3D models from human tissue to understand the effects that a drug—a cyclophilin inhibitor—has on liver tissue damaged by alcohol. They found that the drug stops the build-up of proteins responsible for making the tissue stiff—a characteristic of liver disease—allowing the liver to remodel itself back to a healthier state.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup